Natera
Medtech · Public
Non-invasive prenatal testing (NIPT) and circulating tumor DNA (ctDNA) diagnostic tests
natera.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1.9M
- 12 awards · Veterans Affairs
- #233 of 4531 in medtech
- Patents
- 40
- 23 granted · 17 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202220232024202520262027
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Veterans Affairs · Minimal Residual Disease Testing Services | $92,391 | |
| Federal contract | Department of Veterans Affairs · Task Order To Fund Mrdt For FY24 | $496,460 | |
| Federal contract | Department of Veterans Affairs · New Task Order To Extend The Pop For Six (6) Months | $499,447 | |
| Federal contract | Department of Veterans Affairs · Tumor Whole Exome Sequencing (wes) And Peripheral Blood Ctdna Test Testing (single Assay) Services And Wes Data Transfer/ Reporting | $123,950 | |
| Federal contract | Department of Veterans Affairs · Next Generation Sequencing And Peripheral Blood Ctdna Testing Services (research) | $42,000 | |
| Federal contract | Department of Veterans Affairs · Modification To Extend The Pop For Six (6) Months | $140,595 | |
| Federal contract | Department of Veterans Affairs · Genetic Testing | $82,500 | |
| Federal contract | Department of Veterans Affairs · Next Generation Sequencing And Peripheral Blood Ctdna Testing Services (research) | $73,500 | |
| Federal contract | Department of Veterans Affairs · Natera Kidney Disease Genetic Panel Testing | $157,000 | |
| Federal contract | Department of Veterans Affairs · EO 14398 Genetic Testing Services For P&lms, Little Rock, Ar. | $110,000 | |
| Federal contract | Department of Veterans Affairs · Renasight Testing Service At Durham Vamc | $48,000 |
Federal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 230 | Accelerate Diagnostics, Inc | $1.9M | $105M |
| 231 | EarlySense | $1.9M | — |
| 232 | ARETECH, LLC | $1.9M | — |
| 233 | Natera | $1.9M | — |
| 234 | ACCELERATED MEDICAL DIAGNOSTICS, INC | $1.9M | — |
| 235 | SYLVATICA BIOTECH INC | $1.8M | — |
| 236 | Redbud Labs, Inc. | $1.8M | $520K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Systems And Methods For Determining Aneuploidy Risk Using Sample Fetal Fractiongranted
- Methods For Simultaneous Amplification Of Target Locigranted
- Methods For Simultaneous Amplification Of Target Locigranted
- Methods For Assessing Graft Suitability For Transplantationapplication
- Detecting Mutations And Ploidy In Chromosomal Segmentsapplication
- Methods For Simultaneous Amplification Of Target Locigranted
- Methods And Compositions For Determining Ploidygranted
- Detecting Disease And Ploidy In Chromosomal Segmentsgranted
- Detecting Mutations And Ploidy In Chromosomal Segmentsapplication
- Methods For Simultaneous Amplification Of Target Locigranted
- Methods For Simultaneous Amplification Of Target Locigranted
- Methods For Simultaneous Amplification Of Target Locigranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.